Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers
Status:
Not yet recruiting
Trial end date:
2021-08-16
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label, single dosing, 3-treatment, 6-sequence, 3-period,
crossover-design study to compare the pharmacokinetics and safety of D113 with CKD-349 in
healthy volunteers.